30.75BMarket Cap-14.61P/E (TTM)
28.150High27.400Low1.84MVolume27.650Open27.450Pre Close51.21MTurnover0.17%Turnover RatioLossP/E (Static)1.09BShares28.50052wk High5.93P/B30.75BFloat Cap10.56052wk Low--Dividend TTM1.09BShs Float151.200Historical High--Dividend LFY2.73%Amplitude10.560Historical Low27.853Avg Price100Lot Size--Div YieldTTM--Div Yield LFY
ZAI LAB Stock Forum
Zai Lab (NASDAQ: ZLAB; HKEX: 9688) has received Orphan Drug Designation (ODD) from the U.S. FDA for ZL-1310, their first-in-class DLL3 antibody-drug conjugate (ADC) designed to treat small cell lung cancer (SCLC). The designation comes after promising results from an ongoing Phase 1a/1b study in patients with previously treated extensive-stage SCL...
No comment yet